SCHEMBL20119174

SCHEMBL20119174

CN1CCCc2ccc(C(=O)O)cc21

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
ACHE P22303 3/20 0.54
GAA P10253 4/20 0.48
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 1/20 0.46
TRPV1 Q8NER1 2/20 0.46
KDM4E B2RXH2 3/20 0.44
AKR1C3 P42330 1/20 0.44
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12193492 0.92 ALDH1A1 (0.49) ALDH1A1ACHEGAAKDM4EAKR1C3
SCHEMBL30219277 0.87 ACHE (0.49) ALDH1A1ACHEGAAKMT2AMAPT
SCHEMBL2817935 0.87 ALDH1A1 (0.58) ALDH1A1ACHEGAAKMT2AMAPT
SCHEMBL30041535 0.87 ALDH1A1 (0.58) ALDH1A1ACHEGAAKMT2AMAPT
SCHEMBL553563 0.84 KDM4E (0.57) ALDH1A1ACHEGAAKMT2AMEN1
SCHEMBL18612697 0.84 HDAC6 (0.55) ACHETRPV1
SCHEMBL20119292 0.81 RARA (0.51) ALDH1A1ACHEGAAKMT2AMEN1
SCHEMBL20178644 0.80 ALDH1A1 (0.56) ALDH1A1ACHEGAAKMT2AMAPT
SCHEMBL13572030 0.80 ALDH1A1 (0.56) ALDH1A1GAAKMT2AMAPTMEN1
SCHEMBL20178668 0.80 ALDH1A1 (0.51) ALDH1A1ACHEGAAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2020-03-24 US disclosed
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-05-24 US disclosed
WO-2018081285-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF NR1H4, FXR1, SLC10A1 ALDH1A1 2185/4885ACHE 4086/4885GAA 506/4885
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof NR1H4, FXR1, SLC10A1 ALDH1A1 2185/4885ACHE 4086/4885GAA 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.